Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  European Journal of Pharmacology

• Publication date

  1989-04-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(89)90194-5PMID 2721574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Human Platelet Aggregation and Cytoplasmic Calcium Response by Calcium Antagonists: Studies with Aequorin and Quin2

  1986cited by this paper
• Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).

  1986cited by this paper
• Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.

  1985cited by this paper
• Prostaglandins and cardiovascular disease--a review.

  1983cited by this paper
• Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.

  1982cited by this paper
• Inhibiton of platelet aggregation by 1-alkylimidazole derivatives, thromboxane a synthethase inhibitors

  1981cited by this paper
• Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.

  1981cited by this paper
• Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.

  1981cited by this paper
• Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents.

  1980cited by this paper
• Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes.

  1979cited by this paper
• Platelet and blood vessel arachidonate metabolism and interactions.

  1979cited by this paper
• 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.

  1979cited by this paper
• pA2 and receptor differentiation: a statistical analysis of competitive antagonism.

  1979cited by this paper
• Experimental ischemic heart disease--effects of synthetic thromboxane A2.

  1979cited by this paper
• Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets.

  1977cited by this paper
• An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue.

  1977cited by this paper
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

  1976cited by this paper
• Thromboxanes: selective biosynthesis and distinct biological properties.

  1976cited by this paper
• Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes.

  1976cited by this paper
• The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation.

  1976cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper

• Evaluation of platelet function under high shear condition in the small-sized collagen bead column.

  2005cites this paper
• Different prostanoids are involved in bradykinin-induced endothelium-dependent and -independent vasoconstriction in rat mesenteric resistance arteries.

  2004cites this paper
• The Arachidonic Acid Cascade: Thromboxane A2 Antagonism and Synthetase Inhibition in Experimental Myocardial Infarction

  2004cites this paper
• Mechanisms of platelet retention in the collagen-coated-bead column.

  2003cites this paper
• Mechanisms of platelet retention in the collagen-coated–bead column

  2003cites this paper
• Nitric oxide‐induced Cl− secretion in isolated rat colon is mediated by the release of thromboxane A2

  2002cites this paper
• Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase.

  1999cites this paper
• Thromboxane A2, released by the anti‐ tumour drug irinotecan, is a novel stimulator of Cl− secretion in isolated rat colon

  1997cites this paper
• Inhibitory actions of ONO-3708 on the stretch-induced contraction potentiated by hemolysate/oxyhemoglobin studied in dog cerebral artery.

  1997cites this paper
• Unstimulated polymorphonuclear neutrophils regulate proximal coronary arterial tone.

  1997cites this paper
• Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins.

  1996cites this paper
• Characterization of the prostanoid TP receptor population in human nonpregnant myometrium.

  1996cites this paper
• Mechanisms of epidermal growth factor-induced contraction of guinea pig airways.

  1996cites this paper
• Possible involvement of protein-tyrosine kinases such as p72syk in the disc-sphere change response of porcine platelets.

  1995cites this paper
• Protective effect of the thromboxane A2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver.

  1994cites this paper
• Prevention of Intra-Coronary Thrombosis in the Anaesthetised Dog: The Importance of Thromboxane A2 and Thrombin

  1994cites this paper
• The effect of a thromboxane A2 receptor antagonist (ONO 3708) on ischemia-reperfusion injury of the dog pancreas.

  1994cites this paper
• Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.

  1994cites this paper
• Different modes of endothelin-1 action in pressor response in vivo and pulmonary parenchymal contraction in vitro in the guinea pig.

  1993cites this paper
• Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis.

  1993cites this paper
• Protein-tyrosine kinase p72syk is activated by thromboxane A2 mimetic U44069 in platelets.

  1993cites this paper
• Platelets Enhance Anoxic Contraction of Rat Aortic Rings Through Platelet‐Activating Factor‐Dependent Mechanism

  1993cites this paper
• Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed.

  1992cites this paper
• Thromboxane A2 receptor antagonists

  1991cites this paper
• [Effect of (+)-S-145 calcium salt dihydrate, an orally active antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation].

  1991cites this paper
• Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.

  1991cites this paper
• Current concepts for a drug-induced inhibition of formation and action of thromboxane A2

  1990cites this paper
• The Potential Role of Thromboxane Inhibitors in Preventing Myocardial Ischaemic Injury

  1990cites this paper
• Cooperativity between platelet‐activating factor and collagen in aggregation of bovine platelets III

  1990cites this paper
• Chapter 11. Thromboxane Synthase Inhibitors and Receptor Antagonists

  1990cites this paper
• Changes in urinary thromboxane level in man during cardiopulmonary bypass: Effect of thromoboxane on renal tubules

  1990cites this paper
• Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on blood vessels.

  1989cites this paper
• Changes in urinary thromboxane level in man during cardiopulmonary bypass: effect of thromboxane on renal tubules.

  1989cites this paper